Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ACTC > SEC Filings for ACTC > Form 8-K on 29-May-2014All Recent SEC Filings

Show all filings for ADVANCED CELL TECHNOLOGY, INC.

Form 8-K for ADVANCED CELL TECHNOLOGY, INC.


29-May-2014

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 22, 2014, Advanced Cell Technology, Inc. (the "Company") entered into an amended and restated employment agreement (the "Agreement") with Edward Myles. The agreement replaces the employment agreement between the Company and Mr. Myles executed in May 2013 pursuant to which Mr. Myles served as the Company's Chief Financial Officer and Executive Vice President of Corporate Development.

Pursuant to the Agreement, Mr. Myles will receive an annual base salary of $360,000 and will serve as the Company's Chief Operating Officer and Chief Financial Officer. Mr. Myles will be eligible to receive an annual cash incentive bonus with a target amount equal to 35% of his annual base salary. The actual amount of the performance bonus will be determined by the Company's board of directors, and may be more or less than the target amount. Mr. Myles will also be entitled to continue to participate in the benefits and insurance programs generally available to all Company employees.

If Mr. Myles' employment is terminated by the Company without cause or by Mr. Myles for good reason, then Mr. Myles will be eligible to receive (a) a continuation of base salary for twelve (12) months; (b) a lump-sum payment equal to 35% of his annual base salary; (c) continuation of group health plan benefits for up to twelve (12) months to the extent authorized by and consistent with 29 U.S.C. 1161 et seq. (commonly known as "COBRA"); (d) twelve (12) months of accelerated vesting on all outstanding equity incentive awards to the extent subject to time-based vesting; and (e) effectiveness of any performance-based equity awards for three (3) months beyond the date of termination. The payment of these severance payments and benefits is conditioned upon Mr. Myles providing a release of claims.

If Mr. Myles is terminated without cause or he quits for good reason, in either case, within twelve (12) months following a change in control, then he will be entitled to severance as follows: (a) a lump sum payment equal to twelve (12) months of base salary plus the average annual bonus amount paid to Mr. Myles as determined over the three-year period immediately preceding such termination;
(b) continuation of group health plan benefits for up to twelve (12) months to the extent authorized by and consistent with COBRA; and (c) 100% acceleration of all outstanding equity inventive awards to the extent subject to time-based vesting.

The foregoing description of the Agreement is qualified in its entirety by reference to the available text of the Agreement, a copy of which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the three months ending June 30, 2014.

  Add ACTC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACTC - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.